Beating earnings estimates typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. The better-than-expected loss reported by 4D Molecular Therapeutics suggests operational efficiency or higher revenue than anticipated, which could positively influence the stock in the short term.